Related Blog Posts from the Wikinvest Wire

Amyris Biotechnologies (AMRS)   Subscribe to Amyris Biotechnologies (AMRS) content from the Wikinvest Wire
 » Back to Amyris Biotechn… (NASDAQ:AMRS) Stock Page


10/18/11Amyris AMRS: My Morning Pick (Morningpick)

I am now adding my morning picks to the quote ticker above, far right, provided by You will see 5 stocks under Morningpick Stocks. The first company corresponds with Monday, the second with Tuesday and so on. Yesterday's pick was Texas Instrument while last weeks (Tuesday to Friday) are still posted until they are replaced with my new picks this week. I will add my morning pick to this quote's applet by 7:30 A.M. every morning so you have a heads up before the market opens. If...

12/30/10NASDAQ most active stocks: (KONE, CACB, AMRS, VIRC, MSHL) (Penny Stock DD)

Kingtone Wirelessinfo Solutions Hldg Ltd (NASDAQ:KONE) jumped up by 14.80% to close at $3.49 with overall traded volume of 85,426 shares in the last trading day. The relative strength index arrives at 44.63 times. Its price to earnings ratio stands at 6.58 times till its last trading day. Cascade Bancorp (NASDAQ:CACB) went up by 13.10% and [...]

11/4/10Amyris Signs Contract Manufacturing Agreement with Tate & Lyle (Benzinga)

Amyris, Inc. (NASDAQ: AMRS) announced today that it has entered into a contract manufacturing agreement with Tate & Lyle Ingredients Americas, Inc., an affiliate of Tate & Lyle PLC (LSE:TATE.l - News). Under this arrangement, Tate & Lyle will produce farnesene at its facilities in Decatur, IL; the produced farnesene will be owned and distributed by Amyris. This arrangement with Tate & Lyle expands Amyris's contracted production capacity. Amyris entered into a similar agreement in June 2010...

5/26/10Amyris IPO Update: DOE Funds Roll In, Losses Top $136M (Clean Energy Sector)

Amyris Biotechnologies has taken one more step toward the long sought goal of commercial scale next-gen biofuel production. The IPO hopeful's latest filing with regulators shows it has collected its first revenue from a multimillion dollar federal grant awarded late last year.

Your blog posts can appear here by joining the Wikinvest Wire
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki